Literature DB >> 7300801

Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.

B Aronsson, R Möllby, C E Nord.   

Abstract

From 1324 patients with antibiotic-associated diarrhea (AAD) 1643 stool samples were analyzed by a cell test for Clostridium difficile toxin in stool filtrates and cultivation for occurrence of C. difficile strains. In patients with no detectable toxin in their stool strains of C. difficile were isolated in 2.2% whereas when toxin was detectable, the isolation rate varied from 17% to 36%. Furthermore, there was a correlation between toxin titre in stool filtrate and production of cytotoxin in vitro by the corresponding C. difficile strains. Five clostridial strains, not belonging to the species C. difficile, were found to produce typical cytotoxin in vitro. However, five strains identified as C. difficile by biochemical reactions and gas liquid chromatography, did not produce an extracellular cytotoxin. The antibiotic susceptibility patterns of the Clostridium strains were investigated. No correlation was recognized between antibiotic resistance of isolated Clostridium strains and the AAD-inducing antibiotic penicillins and linco/clindamycin. Neither did cases of relapse of diarrheal disease after vancomycin treatment harbour C. difficile strains with increased resistance to vancomycin. It is concluded that the pathogenesis of antibiotic-associated enterocolitis is more complex than a mere intestinal overgrowth of resistant strains of C. difficile.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300801     DOI: 10.1007/bf02123794

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  32 in total

1.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

2.  [Antibiotic-induced pseudomembranous colitis].

Authors:  S Eriksson
Journal:  Lakartidningen       Date:  1980-07-23

3.  Spontaneous pseudomembranous colitis.

Authors:  J M Howard; S N Sullivan; M Troster
Journal:  Br Med J       Date:  1980-08-02

4.  Antibiotic susceptibility of Clostridium difficile.

Authors:  D W Burdon; J D Brown; D J Youngs; Y Arabi; N Shinagawa; J Alexander-Williams; M R Keighley; R H George
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

5.  Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters.

Authors:  R Fekety; J Silva; R Toshniwal; M Allo; J Armstrong; R Browne; J Ebright; G Rifkin
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

6.  Role of clostridial toxin in the pathogenesis of clindamycin colitis in rabbits.

Authors:  J T LaMont; E B Sonnenblick; S Rothman
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

7.  Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin.

Authors:  F C Knoop
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

8.  Clostridium difficile in relation to enteric bacterial pathogens.

Authors:  E Falsen; B Kaijser; L Nehls; B Nygren; A Svedhem
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  Is pseudomembranous colitis infectious?

Authors:  C Greenfield; A Burroughs; M Szawathowski; N Bass; P Noone; R Pounder
Journal:  Lancet       Date:  1981-02-14       Impact factor: 79.321

10.  Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis.

Authors:  S R Peikin; J Galdibini; J G Bartlett
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

View more
  10 in total

1.  Quantitative measurement of biliary excretion and of gall bladder concentration of drugs under physiological conditions in man.

Authors:  A Lanzini; M G Pigozzi; A Wuhrer; D Facchinetti; M Castellano; L Bettini; U P Guerra; M Beschi; G Muiesan
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Intestinal colonization with Clostridium difficile in infants up to 18 months of age.

Authors:  K Tullus; B Aronsson; S Marcus; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

4.  Clostridium difficile-associated diarrhoea in uremic patients.

Authors:  B Aronsson; P Barany; C E Nord; B Nyström; P Stenvinkel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

5.  Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

Review 6.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

7.  Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

8.  Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.

Authors:  Xiang-He Lei; Barry R Bochner
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Novel bacterial taxa in the human microbiome.

Authors:  Kristine M Wylie; Rebecca M Truty; Thomas J Sharpton; Kathie A Mihindukulasuriya; Yanjiao Zhou; Hongyu Gao; Erica Sodergren; George M Weinstock; Katherine S Pollard
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

10.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.